FindTrial
Sign In

NON APPLICABILE - ND

NON APPLICABILE - ND

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-003672-19-IT
Enrollment
Unknown
Registered
2007-07-02
Start date
2006-10-24
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immunosoppressive therapy in liver transplanted patients. MedDRA version: 9.1 Level: LLT Classification code 10050434 Term: Prophylaxis against liver transplant rejection

Interventions

Trade Name: CERTICAN Pharmaceutical Form: Tablet INN or Proposed INN: Everolimus Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 1.5- Trade Name: SANDIMMUN NEORAL

Sponsors

AZIENDA OSPEDALIERA POLICLINICO DI MODENA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: non applicabile Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: non applicabile

Design outcomes

Primary

MeasureTime frame
Main Objective: NON APPLICABILE;Secondary Objective: non applicabile;Primary end point(s): non applicabile—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026